arigo Biolaboratories

arigo Biolaboratories develops research reagents for protein detection, biomarker analysis and cell signalling studies. Its products support scientists across a broad range of life science disciplines. The company specialises in antibodies, antibody duos, antibody panels and immunoassays. These tools help researchers investigate biological pathways, quantify target proteins and validate experimental findings. Arigo’s reagents are widely used in immunology, cancer research, neuroscience, metabolism, infectious disease, cell biology and signal transduction studies. The company also provides pathway-focused reagent collections for areas such as ferroptosis, pyroptosis, inflammasome activation, tumour microenvironment biology and exosome research.

The portfolio includes primary and secondary antibodies, ELISA kits, recombinant proteins and rabbit monoclonal antibodies. Arigo also offers the arigoPLEX® multiplex ELISA platform for simultaneous measurement of multiple cytokines or biomarkers in a single assay. Its antibody duos and pathway-oriented panels support protein interaction studies, post-translational modification analysis and biomarker validation workflows. These products are used in assay development, translational research, disease mechanism studies and routine laboratory investigations.